(CIDRAP News) – Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) have determined that a single injection of a fast-acting experimental Ebola vaccine confers protection against the disease in monkeys after just 1 month.
(CIDRAP News) – Researchers at the University of Wisconsin at Madison (UW-Madison) worked on Ebola virus genetic material in a lab that lacked the required security measures, and federal agencies responsible for monitoring compliance didn't notice the problem, a watchdog group that monitors biodefense research safety reported recently.
(CIDRAP News) The United States could be the next country to experience an epidemic of dengue illnesses if the disease keeps aggressively expanding, senior officials from the National Institute of Allergy and Infectious Diseases (NIAID) warned this week.
(CIDRAP News) The National Institute of Allergy and Infectious Diseases (NIAID) has launched a clinical trial of a dengue virus vaccine, a product that eventually may help prevent a disease to which 2.5 billion people are exposed.
The launching of a trial at the Johns Hopkins Bloomberg School of Public in Baltimore and the University of Vermont in Burlington follows more than a decade of development, the NIAID said in a press release.